Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Measles

Measles is a highly contagious infectious disease that can cause severe, long-term complications in children.

Research

Heritable and environmental determinants of hospitalisation for common childhood illnesses

We will leverage the unique Western Australian data linkage resources to undertake the definitive twin and sibling study of infection-related hospitalisation

Research

GAMA project

This study investigated host gene expression in response to new HIV infection.

Research

Convalescent plasma in hospitalised patients with COVID-19

Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.

Research

Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions

Since their first detection in 2010, Plasmodium falciparum malaria parasites lacking the P. falciparum histidine-rich protein 2 gene (pfhrp2) have been observed in 40 of 47 surveyed countries, as documented by the World Health Organization. These genetic deletions reduce detection by the most widely used rapid diagnostic tests, prompting three countries to switch to alternative diagnostics.

News & Events

The Kids researcher wins Premier’s Science Award

The Kids researcher Dr Hannah Moore has been named Woodside Early Career Scientist of the Year at the 2015 Premier's Science Awards.

News & Events

Infection takes high toll in young children

A new study has found that infectious diseases are the most common reason that children under two years of age are admitted to hospital.

News & Events

Perth children and seniors needed for bird flu vaccine study

Perth researchers have begun a trial to test the effectiveness in children and seniors of a new vaccine to protect against the potentially deadly bird flu.

Research

RSV: an update on prevention and management

Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections in infants and young children, and adults over 60 years of age. Infants born prematurely, adults aged over 75 years, individuals with medical conditions such as chronic cardiac or respiratory disease, or obesity, and Aboriginal and Torres Strait Islander people are at increased risk of severe RSV disease. 

Research

Pediatric Bronchiectasis Action Management Plan to Improve Clinical Outcomes: A Randomized Controlled Trial

Managing bronchiectasis exacerbations is a priority for patients, parents, and caregivers of children with bronchiectasis. However, evidence-based strategies among the pediatric population remain limited.